Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat + Exemestane in Advanced ER+ Breast Cancer (ENCORE 301)
NCT00676663Phase 2Completed
- Sponsor
- Syndax Pharmaceuticals
- Start
- Jun 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of entinostat in breast cancer, sponsored by Syndax Pharmaceuticals. Started Jun 2008; status: completed.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00676663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00676663.